Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells

[1]  D. Faller,et al.  A Novel DNA Damage Checkpoint Involving Post-transcriptional Regulation of Cyclin A Expression* , 2000, The Journal of Biological Chemistry.

[2]  E. Wagner,et al.  c-Jun-Dependent CD95-L Expression Is a Rate-Limiting Step in the Induction of Apoptosis by Alkylating Agents , 2000, Molecular and Cellular Biology.

[3]  V. Rotter,et al.  Epithelial cells of different organs exhibit distinct patterns of p53-dependent and p53-independent apoptosis following DNA insult. , 1999, Experimental cell research.

[4]  Matthew W. Strobeck,et al.  Cyclin A Is a Functional Target of Retinoblastoma Tumor Suppressor Protein-mediated Cell Cycle Arrest* , 1999, The Journal of Biological Chemistry.

[5]  D. Bar-Sagi,et al.  Suppression of Ras-Induced Apoptosis by the Rac GTPase , 1999, Molecular and Cellular Biology.

[6]  T. Nomura,et al.  Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis , 1999, Oncogene.

[7]  A. Weiss,et al.  Induction of NF-κB by the Akt/PKB kinase , 1999, Current Biology.

[8]  V. Rotter,et al.  Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress , 1999, Oncogene.

[9]  K. Varga,et al.  Unbound states by analytic continuation in the coupling constant , 1999 .

[10]  R. Brown,et al.  p53-oriented cancer therapies: current progress. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Lars E. French,et al.  The TRAIL to selective tumor death , 1999, Nature Medicine.

[12]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[13]  E. Reddy,et al.  Modulation of life and death by the TNF receptor superfamily , 1998, Oncogene.

[14]  D. Geschwind,et al.  Genomic organization, 5' flanking enhancer region, and chromosomal assignment of the cell cycle gene, p55Cdc. , 1998, Molecular genetics and metabolism.

[15]  R. Weichselbaum,et al.  Activation of protein kinase C δ by the c-Abl tyrosine kinase in response to ionizing radiation , 1998, Oncogene.

[16]  G. Evan,et al.  Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation , 1997, The EMBO journal.

[17]  V. D’Agati,et al.  C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.

[18]  J Weinstein,et al.  Cell Cycle-regulated Expression, Phosphorylation, and Degradation of p55Cdc , 1997, The Journal of Biological Chemistry.

[19]  I. Herr,et al.  Activation of CD95 (APO‐1/Fas) signaling by ceramide mediates cancer therapy‐induced apoptosis , 1997, The EMBO journal.

[20]  I. Herr,et al.  The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. , 1997, Cancer research.

[21]  R. Gentz,et al.  An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.

[22]  T. Gura.  How TRAIL Kills Cancer Cells, But Not Normal Cells , 1997, Science.

[23]  C. Potten,et al.  Apoptosis in small intestinal epithelia from p53-null mice: evidence for a delayed, p53-indepdendent G2/M-associated cell death after γ-irradiation , 1997, Oncogene.

[24]  Arul M. Chinnaiyan,et al.  The Receptor for the Cytotoxic Ligand TRAIL , 1997, Science.

[25]  P. Galle,et al.  Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. , 1997, The Journal of clinical investigation.

[26]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[27]  I. Herr,et al.  Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.

[28]  C. Hunt,et al.  The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation , 1996, Molecular and cellular biology.

[29]  N. Zaffaroni,et al.  Effect of ionizing radiation on cell‐cycle progression and cyclin B1 expression in human melanoma cells , 1996, International journal of cancer.

[30]  A. Chinnaiyan,et al.  FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[31]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[32]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[33]  M. Akashi,et al.  Irradiation Induces WAF1 Expression through a p53-independent Pathway in KG-1 Cells (*) , 1995, The Journal of Biological Chemistry.

[34]  M. Prados,et al.  Constitutional p53 mutations associated with brain tumors in young adults. , 1995, Cancer genetics and cytogenetics.

[35]  J. Roth,et al.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.

[36]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[37]  A. Planas,et al.  Evidence of internucleosomal DNA fragmentation and identification of dying cells in X-ray-induced cell death in the developing brain , 1995, International Journal of Developmental Neuroscience.

[38]  N. Copeland,et al.  Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. , 1994, Genes & development.

[39]  P. Barr,et al.  Apoptosis and Its Role in Human Disease , 1994, Bio/Technology.

[40]  L. Tartaglia,et al.  A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.

[41]  R. Weichselbaum,et al.  Down-regulation of cell cycle control genes by ionizing radiation. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[42]  I. Ferrer.  The effect of cycloheximide on natural and X-ray-induced cell death in the developing cerebral cortex , 1992, Brain Research.

[43]  R. Muschel,et al.  Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. , 1991, Cancer research.

[44]  P. Steinbok,et al.  Superfractionated radiotherapy in grade III, IV intracranial gliomas. , 1988, International journal of radiation oncology, biology, physics.

[45]  N Albright,et al.  Computer programs for the analysis of cellular survival data. , 1987, Radiation research.

[46]  B. Fertil,et al.  Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. , 1985, International journal of radiation oncology, biology, physics.

[47]  G. Sheline.  Radiation therapy of brain tumors , 1977, Cancer.

[48]  W. El-Deiry,et al.  Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.

[49]  M. Prados,et al.  Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. , 1998, International journal of radiation oncology, biology, physics.

[50]  I. Krantz,et al.  KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene , 1997, Nature Genetics.

[51]  W. Dewey,et al.  p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. , 1996, International journal of radiation oncology, biology, physics.

[52]  A. Taghian,et al.  In vitro intrinsic radiation sensitivity of glioblastoma multiforme. , 1992, International journal of radiation oncology, biology, physics.

[53]  S. Murphy.  Generation of Astrocyte Cultures from Normal and Neoplastic Central Nervous System , 1990 .